EBS vs FAST · rev $1.04B vs P/E 43, rev $7.55B
Emergent Biosolutions Inc (EBS) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
EBS currently screens at market cap $416.4M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the EBS and FAST stock pages for the full models.
Not investment advice.